Cargando…
The potential applications of microparticles in the diagnosis, treatment, and prognosis of lung cancer
Microparticles (MPs) are 100–1000 nm heterogeneous submicron membranous vesicles derived from various cell types that express surface proteins and antigenic profiles suggestive of their cellular origin. MPs contain a diverse array of bioactive chemicals and surface receptors, including lipids, nucle...
Autores principales: | Liu, Yu, Wang, Sufei, Xia, Hui, Tan, Xueyun, Song, Siwei, Zhang, Shujing, Meng, Daquan, Chen, Qing, Jin, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444106/ https://www.ncbi.nlm.nih.gov/pubmed/36064415 http://dx.doi.org/10.1186/s12967-022-03599-x |
Ejemplares similares
-
Prognosis prediction of icotinib as targeted therapy for advanced EGFR-positive non–small cell lung cancer patients
por: Tan, Xueyun, et al.
Publicado: (2023) -
Role of macrophage in nanomedicine-based disease treatment
por: Song, Siwei, et al.
Publicado: (2021) -
Association Between Longitudinal Change in Abnormal Fasting Blood Glucose Levels and Outcome of COVID-19 Patients Without Previous Diagnosis of Diabetes
por: Song, Siwei, et al.
Publicado: (2021) -
Plasma Metabolomic Profiles in Recovered COVID-19 Patients without Previous Underlying Diseases 3 Months After Discharge
por: Zhang, Shujing, et al.
Publicado: (2021) -
Nanopore membrane chip-based isolation method for metabolomic analysis of plasma small extracellular vesicles from COVID-19 survivors
por: Huang, Qi, et al.
Publicado: (2023)